Tegaserod maleate has been shown to exert anticancer activity by inducing apoptosis in melanoma cells (27), and it has been identified as a JAK/STAT3 signal inhibitor, impeding the growth of a variety of cancer cells, including lung cancer, prostate cancer, colon cancer, and cervical cancer (28). The gene discussed is STAT3; the disease is cervical cancer.